Health Trials

Waldenstrom Macroglobulinemia Wm

2

Review clinical trials related to Waldenstrom Macroglobulinemia Wm. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

A Study of NX-5948 in Adults With Relapsed/Refractory B-cell Malignancies

This is a first-in-human Phase 1a/1b multicenter, open-label study designed to evaluate the safety and anti-cancer activity of NX-5948 in patients with advanced B-cell malignancies.

Participants needed: 572
Trial details
Phase: Phase 1Age: 18+Biological sex: AllType: InterventionalSponsor: Nurix Therapeutics, Inc.Updated: Jul 2, 2026Locations: 62
Eligibility criteria

Age ≥18 years [+5]

Known or suspected active prolymphocytic leukemia or Richter's transformation to... [+17]

Read more
Status: Recruiting

A Study of NX-2127 in Adults With Relapsed/Refractory B-cell Malignancies

This is a first-in-human Phase 1a/1b multicenter, open-label oncology study designed to evaluate the safety and anti-cancer activity of NX-2127 in patients with advanced B-cell malignancies.

Participants needed: 248
Trial details
Phase: Phase 1Age: 18+Biological sex: AllType: InterventionalSponsor: Nurix Therapeutics, Inc.Updated: Mar 20, 2026Locations: 16
Eligibility criteria

Patients must be ≥ 18 years of age [+3]

Eastern Cooperative Oncology Group (ECOG) performance status of 0 or 1 (non-PCNS... [+26]

Read more